| Kori Mitteer, CNM | |
|
655 S Dobson Rd, Suite 101a, Chandler, AZ 85224-5667 | |
| (480) 855-5900 | |
| Not Available |
| Full Name | Kori Mitteer |
|---|---|
| Gender | Female |
| Speciality | Advanced Practice Midwife |
| Location | 655 S Dobson Rd, Chandler, Arizona |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1366981821 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 367A00000X | Advanced Practice Midwife | AP9888 (Arizona) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Kori Mitteer, CNM 655 S Dobson Rd, Suite 101a, Chandler, AZ 85224-5667 Ph: (480) 855-5900 | Kori Mitteer, CNM 655 S Dobson Rd, Suite 101a, Chandler, AZ 85224-5667 Ph: (480) 855-5900 |
News Archive
The European Society for Medical Oncology (ESMO) announced today the names of two eminent cancer specialists and one European institution that will be recognized for their contribution to the advancement of medical oncology at the ESMO 2012 Congress.
Tobii Technology, the global market leader in eye tracking, today announces the launch of Tobii Glasses™ a revolutionary, cost-effective eye tracking system. Tobii Glasses will help researchers in commercial, scientific, and government organisations to gain greater levels of insight into the preferences, reactions and personal experiences of people in a natural environment.
The Norwegian healthcare services are organized in primary and secondary service levels. According to PhD student Kristin Laugaland at UiS effective and safe care depends on coordination across the two service levels in which transitions across them represent a crucial stage in the recovery of elderly people.
Chimerix, Inc., a biopharmaceutical company developing orally-available antiviral therapeutics, today announced the publication of research results demonstrating the potential of CMX157 (hexadecyloxypropyl tenofovir) to effectively suppress replication of human immunodeficiency virus (HIV) that cannot be treated with currently available nucleoside/nucleotide reverse transcriptase inhibitors (NRTIs), including tenofovir disoproxil fumarate (Viread), due to the development of multi-drug resistance. Earlier this year, Chimerix initiated a dose-escalating Phase 1 clinical trial of CMX-157 to evaluate drug safety, tolerability and pharmacokinetics.
In genetics, an enhancer is a short region of DNA that can be bound by proteins to increase the likelihood that transcription of a particular gene will occur.
› Verified 4 days ago
Miss Emma Loree White, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 1950 W Frye Rd, Chandler, AZ 85224 Phone: 480-895-9555 | |
Mrs. Danielle Marie Salazar, CNM, WHNP-BC Advanced Practice Midwife Medicare: Accepting Medicare Assignments Practice Location: 1950 W Frye Rd Bldg B, Chandler, AZ 85224 Phone: 480-895-9555 | |
Mina Hignutt, Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 655 S Dobson Rd Ste 101, Chandler, AZ 85224 Phone: 480-459-2555 Fax: 480-378-3131 | |
Janelle Skarphol, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2545 W Frye Rd Ste 5, Chandler, AZ 85224 Phone: 480-821-3600 Fax: 480-821-3610 | |
Karla L Hill, CNM Advanced Practice Midwife Medicare: Medicare Enrolled Practice Location: 2055 W Frye Rd Ste 9, Chandler, AZ 85224 Phone: 480-821-3600 Fax: 480-821-3610 | |
Yingxin Yang, CNM Advanced Practice Midwife Medicare: Not Enrolled in Medicare Practice Location: 2545 W Frye Rd, Chandler, AZ 85224 Phone: 303-243-2429 |